ENTX (Entera Bio) Company Cash Volume

Symbol and logo of brand enterabio.com (ENTX)

The cash balance indicator demonstrates the liquidity of Entera Bio Ltd. (ENTX), where 0.27 expresses the current value of the metric. This trend is supported by the licensing of oral drug delivery systems through partnerships with industry behemoths. Cost optimization is achieved by outsourcing production and testing to third-party contractors. Despite its Israeli origin, the business's humanitarian profile offsets geopolitical threats.

Entera Bio Ltd. - ENTX Company Cash Balance (period 07/04/2022 - 11/21/2026)

Analytical breakdowns and data insights for company enterabio.com (ENTX)

- stock value and consensus price forecast:
- business market valuation indicators:
Analysis of all company metrics:Entera Bio Ltd. ENTX
Brand item of Entera Bio Ltd.

Liquidity balance is critical for Entera Bio Ltd. (ENTX) within the biopharmaceutical sector due to the high costs of clinical trials. By analyzing changes in cash levels, investors assess the company's ability to fund the salaries of scientists and experts without resorting to expensive debt capital. Stable dynamics for this metric confirm the business's operational resilience and justify the market value of assets during the drug development phase.

Direct competitors

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance